Table 4.

Multivariable Analysis of All-Cause Mortality Within 90 Days in 147 Human Immunodeficiency Virus-Uninfected Patients With Cryptococcosis

Variable	Hazard Ratio	(95% CI)	P Value
ID consultation	0.24	(.13–.45)	<.001
Age >55 y	3.2	(1.5–7.2)	.003
Positive serum CrAg	5.7	(2.1–15.5)	.001
End-stage liver disease	2.4	(1.2–4.6)	.011
Receipt of chemotherapya	2.1	(1.1–3.9)	.020

Abbreviations: CI, confidence interval; CrAg, cryptococcal antigen; ID, infectious disease.

^aReceipt of chemotherapeutic agent within 90 days.